← Alla produkter

Pure Resveratrol

Sirtuin activator · Powder · 30 portioner#7 / 17 in Sirtuin activator
6.1
Overall score · out of 10
6.1
Overall score · out of 10
Dose vs. studies4.1
Transparency9.5
Value9.2
Community7.5
Formulation5.0
Tier 3
Ingredient RCT (matching dose)
The ingredient was tested in an RCT at the same dose this product sells.
Redaktionellt score, paid $0 No affiliate link Tested by independent lab Public analysintyg Sample received: No
How we scored this product Show the full breakdown
Composite How this 6.1 is built. 0.55 × 4.1 + 0.20 × 9.5 + 0.10 × 9.2 + 0.10 × 7.5 + 0.05 × 5.0 = 6.1 out of 10. Säkerhet caps applied after. 6.1
6.1 composite
Dose vs. studies55%4.1
Transparency20%9.5
Value10%9.2
Community10%7.5
Formulation5%5.0

Bevisning gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Säkerhet caps applied after weighting.

This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.

Read the full method →

Question 1

Does the molecule work?

The science behind each active ingredient, independent of which brand sells it.

The famous red-wine molecule; longevity claims have outrun the human evidence.

3 landmark RCTs · US: Dietary supplement · EU: Authorised Novel Food (2016/1866)
Question 2

Is this bottle good?

The specific product: dose, price, transparency, and what buyers report.

Dose vs research
200% av studiedosen
Meets or exceeds the published effective dose
Cost at trial dose
$0.67/day at trial dose
What one effective daily dose actually costs
Transparency
9.5/10 · Public analysintyg (quality: not assessed)
Independent batch testing confirmed
Consumer signals
No consumer signals collected yet
Operational signal only, never used as clinical evidence
Question 3

What's the catch?

Säkerhet flags, transparency gaps, dosing concerns, and recurring buyer complaints.

Säkerhet signals
Drug interaction risk — resveratrol
Resveratrol inhibits CYP3A4, CYP2C9, and CYP2D6 at doses ≥1,000 mg/day. Potential interactions with warfarin, statins, and NSAIDs.
Läs mer
No major red flags
Public analysintyg, tested by independent lab, dose within range
No safety, transparency, or dose concerns detected at this time.
Redaktionellt verdict

Quick verdict

6.1 / 10
Best for
Full trial dose, Public analysintyg
Avoid if
No major red flags
Full-dose status
Meets trial dose
Pris/month
$40
COA status
Public
Biggest caveat
No significant caveats at this time.
Nearest alternatives

The numbers

Pris
$40
per bottle · 30 portioner
Dose vs. research
Above trial dose 200%
of published effective dose
$ / day at studied dose
$0.67
what one effective daily dose costs
$ / g active
$1.33
per gram of active substance
Independently checked

Data verification

Pris
$40
Verified n/a
Dose
200% av studiedosen
Verified n/a
COA status
Public
Verified n/a
Bevisning grade
C
Per-ingredient breakdown
CResveratrol
Verified n/a

All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Bevisning grades are reviewed when new human RCTs are published. Read how we verify.

What's inside

Ingredient
Dose in this product
Trial dose
Bevisning
Resveratrol
The famous red-wine molecule; longevity claims have outrun the human evidence.
1000 mg 200% av studiedosen
500 mg
3.8 /5
Medium confidence
Rated on 2 platforms (2 sources, no structured review counts)
Source diversity: 46%
Examine.comTrustpilot
PraiseBrand-level rating 4.6/5. Users like the ≥98% trans-resveratrol purity claim.
Last checked: 2026-08-07

Consumer signals

Consumer signals gathered from 2 platforms.

Medium confidence

Consumer sentiment compiled from 2 public sources (Examine.com, Trustpilot).

mixed sentiment

ThemesExamine notes resveratrol's bioavailability is poor and clinical benefit inconsistent, irrespective of brand.

Compiled from a Examine.com listing located during manual research; not independently re-verified against the live page at build time.

4.6/5 · positive sentiment

PraiseBrand-level rating 4.6/5. Users like the ≥98% trans-resveratrol purity claim.

Compiled from a Trustpilot listing located during manual research; not independently re-verified against the live page at build time.

These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.

What others say, with a source hierarchy

We treat external opinion very differently depending on where it comes from. Tier A is our strongest signal. Tier C is background sentiment only. Tier Rejected is what we excluded, listed openly so you can see what we discarded.

These reviews are aggregated from third-party sources, not written by NO1GEVITY. Each entry shows its source, retrieval date, and whether the source has an affiliate or paid relationship. We do not edit reviews to change their meaning. Disclosure policy.

Tier B

Registered dietitians and physicians, without affiliate ties

Credentialed commentary from clinicians who disclose no paid relationship. Useful as supporting critique but not a substitute for a clinical outcome trial.

Physician YouTube analysis — DoNotAge Longevity Sachet
Has affiliate relationship Not a paid placement

Detailed ingredient walk-through. Discount code and buy link present, so the editorial score is discarded; ingredient/dose facts extracted.

How we use it: Ingredient/dose facts only. Redaktionellt rating rejected.
Tier C

Aggregated sentiment (Trustpilot, Reddit)

Mood indicator only. We never use aggregate stars as evidence of efficacy.

Trustpilot — DoNotAge (aggregated sentiment)
No affiliate relationship Not a paid placement

Aggregate score ≈ 4.3-4.5 / 5. Mood indicator only.

Finding: 4.3-4.5 / 5.
How we use it: Sentiment only. Never used as evidence of efficacy.

Community threads and aggregate ratings

Additional public mentions we located, kept separate from the deep independent reviews above.

Examine.com
mixed

Examine notes resveratrol's bioavailability is poor and clinical benefit inconsistent, irrespective of brand.

Read source → Unverified · we received no payment for this listing
Trustpilot · 4.6
positive

Brand-level rating 4.6/5. Users like the ≥98% trans-resveratrol purity claim.

Read source → Unverified · we received no payment for this listing

Vår sammanfattning

Pure Resveratrol is a straightforward ≥98%-purity trans-resveratrol capsule/powder, recommended at 1000 mg/day and priced around $1.80/day at that dose. Resveratrol's SIRT1-activation mechanism has reasonable meta-analytic backing, and one dose-comparison RCT in older diabetics specifically supports 1000 mg/day over 500 mg/day on oxidative-stress markers — a rare case where a vendor's recommended dose lines up closely with what a controlled trial actually tested. That said, resveratrol research overall remains fragmented across doses and populations, individual liver-health claims are uncited, and none of the underlying studies used DoNotAge's specific product.

Bevisning, what actually backs this product

Longevity brands rarely test their exact finished product. We separate what's tested from what's inferred.

Strongest evidence tier
Tier 3Ingredient RCT (matching dose)
4 studies mapped
Tier 3Ingredient RCT (matching dose)
Effect of resveratrol supplementation on oxidative stress markers and SIRT1 in older adults with type 2 diabetes
Various (dose-comparison RCT authors) · 2023 · peer-reviewed clinical nutrition journal (dose-comparison RCT) · n=97 · 1000 mg/day and 500 mg/day, compared head-to-head · 6 months
ingredient-levelpeer-reviewed
This head-to-head dose comparison found the 1000 mg/day group showed a statistically significant improvement in oxidative stress markers and SIRT1 levels compared with both the 500 mg/day group and placebo, directly supporting DoNotAge's higher recommended dose over its lower one.
This is one of the more directly relevant studies in the registry, since it specifically tests DoNotAge's exact 1000 mg/day recommended dose against a lower dose in a controlled design, though the population (older diabetics) may not generalize to a healthy adult consumer.
Conflicts: Academic study; no disclosed link to DoNotAge.
Tier 3Ingredient RCT (matching dose)
Systematic review and metaanalys of resveratrol's effect on SIRT1 gene/protein expression
Various (systematisk översikt authors) · 2025 · peer-reviewed metaanalys (indexed via PubMed) · Ranges across pooled trials, several at or near 1000 mg/day · Varies by pooled trial
ingredient-levelpeer-reviewed
Pooling 11 RCTs, this metaanalys found a statistically significant overall increase in SIRT1 gene and protein expression with resveratrol supplementation, lending some support to the sirtuin-activation mechanism marketed on the product page.
Confirms the SIRT1-activation claim has reasonable meta-analytic support at the gene/protein-expression level, though this is a biomarker outcome, not direct evidence of a clinical anti-aging benefit in healthy people.
Conflicts: Academic metaanalys; no disclosed link to DoNotAge.
Tier 3Ingredient RCT (matching dose)
Systematic review of resveratrol's effect on sirtuin gene expression across randomized controlled trials
Various (systematisk översikt authors) · 2021 · peer-reviewed systematisk översikt · Varies by pooled trial · Varies by pooled trial
ingredient-levelpeer-reviewed
Reviewing 7 RCTs, this earlier systematisk översikt found 4 of 7 trials showed a significant increase in SIRT1 with resveratrol, a more mixed picture than the larger 2025 metaanalys, underscoring inconsistency across smaller individual trials.
Included to show that not all systematic reviews agree, and that resveratrol's SIRT1 effect, while plausible, is not uniformly replicated across every individual trial.
Conflicts: Academic systematisk översikt.
Tier 4Ingredient RCT (different dose)
Systematic review of clinical trials using defined-dose purified resveratrol across multiple conditions
Various (systematisk översikt authors) · 2024 · peer-reviewed systematisk översikt (PMC-indexed) · Highly variable, 5 mg to 5000 mg/day across pooled trials · Variable
ingredient-levelpeer-reviewed
This broad review of purified-resveratrol trials found no consensus treatment regimen across conditions and highlighted substantial knowledge gaps, suggesting the field has not converged on an optimal dose or population for resveratrol's benefits.
Useful context showing resveratrol research overall remains fragmented; it tempers overly confident claims either for or against any single dose, including DoNotAge's 1000 mg recommendation.
Conflicts: Academic review.
Bevisning

Research behind this product

The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.

Claim check, vendor claims vs. our reading of the evidence

Not medical advice. We list the strongest claims made by the brand and check each against traceable evidence.

Partial support
“Pure Resveratrol activates Sirtuin 1 in the body”
A 2025 metaanalys of 11 RCTs found a statistically significant overall increase in SIRT1 expression with resveratrol supplementation, but an earlier 2021 review of 7 RCTs found only 4 of 7 trials showed a significant effect, indicating the finding is directionally supported but not perfectly consistent across all individual studies.
No evidence
“Improves liver health”
No specific liver-health trial is cited on the product page, and the studies located in our research focused on oxidative stress, SIRT1 expression, and diabetes markers rather than liver function endpoints specifically.
Supported
“1000 mg/day recommended dose supports heart health and protects cells from oxidative stress”
A direct head-to-head dose-comparison RCT in older diabetic adults found 1000 mg/day outperformed 500 mg/day on oxidative stress markers over six months, giving reasonable support to DoNotAge's specific recommended dose, though this was studied in a diabetic population rather than healthy consumers generally.

Regelverk status

Rules change often. We record when we last verified each row. See the full regulatory timeline →

US
Legal as supplement
Resveratrol is a long-established dietary supplement ingredient in the US with no equivalent to NMN's drug-preclusion dispute.
Senast verifierad 2026-08-05
EU
Legal as supplement
Trans-resveratrol has an established history of use as a food supplement ingredient across EU member states and is not subject to the same Novel Food uncertainty as NMN.
Senast verifierad 2026-08-05
UK
Legal
Sold as a standard food supplement ingredient in the UK.
Senast verifierad 2026-08-05
CA
Legal as supplement
Resveratrol produkter are commonly licensed as Natural Health Produkter in Canada; specific DoNotAge NPN status was not confirmed.
Senast verifierad 2026-08-05

What we could not verify

We list this openly. If a claim isn't backed by a source we can trace, we'd rather flag it than repeat it.

  • Whether DoNotAge's specific resveratrol extract (as opposed to generic ≥98% trans-resveratrol from other suppliers) has appeared in any published clinical trial was not confirmed.
  • The liver-health claim on the product page could not be traced to a specific supporting study.
Important to know
Resveratrol"Resveratrol" produkter that don't specify trans-isomer content are unmeasurable in practice. Cis-resveratrol is biologically inactive.

Redaktionellt notes

≥98% trans-resveratrol per third-party CoA.

In plain language

Why this scored this way

This DoNotAge Pure Resveratrol scores 6.1, making it below the site average. It delivers the full 1000mg trial dose of Resveratrol with grade C evidence (mostly preclinical, limited human data). Transparency is a clear strength (score: 9.5), with third-party testing and a public analysintyg.

What drives the score up

  • Quality transparency of 9.5: tested by independent lab with a public analysintyg.

What drags it down

  • Dose-evidence score of 4.1 is below average for the site.
  • Resveratrol (1000mg is 200% of the 500mg trial dose) is well above the trial dose. More is not always better.

Why you'd choose it

  • You want good value at $0.67/day.
  • You prioritise tested by independent lab produkter with public lab certificates.

Why you might skip it

  • You want a standard dose of resveratrol (this product is well above it).
  • You want a higher-scoring product (this scores 6.1).
Go deeper

Where this sits

Varumärke owners

Spot an error?

If you are the manufacturer or brand owner of Pure Resveratrol and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.

We review every request, verify it against primär sources, and publish any change with a dated note in the version history above. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.

Request a correction →
Same shelf

Similar produkter

All Sirtuin activator →

The next highest-scoring produkter in Sirtuin activator, same scoring method, same rules.

Same maker

Other produkter from DoNotAge

Varumärke profile →